We studied int-2 and bcl-1 gene amplification in 21 operated patients
with cancer of the larynx. In 9 cases. the int-2 gene was amplified (4
2.9%) and in 4 cases, the hcl-l gene was amplified (25.0%). Go-amplifi
cation of int-2 and bcl-1 was observed in three cases (18.8%), all of
which were glottic carcinomas. Other amplified cases were supraglottic
carcinomas. Tumor specimens with int-2 amplification were associated
with a significantly worse prognosis. We suggest that int-2 amplificat
ion is one of the prognostic factors in laryngectomized patients with
cancer of the larynx.